2026 Annual Meeting | Industry Therapeutic Update from SpringWorks: Clinical Evidence and the Role of Neurologists in Caring for Patients Living With NF1-PN

Date Sunday 04/19/26

Time 11:45 AM - 12:45 PM CDT Add To Calendar

Location McCormick Place West | W471

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Topic(s) Neuro-oncology

Learning Objectives An interactive session focused on Neurofibromatosis Type 1-associated Plexiform Neurofibromas (NF1-PN), the critical role of neurologists in patient care, and strategies to optimize their involvement in co-management and as prescribers of targeted therapies. This program will explore the disease state and address key unmet medical needs, supported by patient case studies that highlight real-world clinical decision-making and outcomes.

CME Available No CME available

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM CDT	Speaker	Industry Therapeutic Update from SpringWorks: Clinical Evidence and the Role of Neurologists in Caring for Patients Living With NF1-PN

Faculty Disclosures
Jessica Schulte, MD	No disclosure on file
Ashley P. Ghiaseddin, MD, FAAN	Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neosoma. Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Deciphera. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio. Dr. Ghiaseddin has or had stock in CRISPR Therapeutics AG.